OraSure Technologies Inc

OSUR

Add to Watchlist

3.000USD

+0.050+1.69%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

OraSure Technologies Inc's Score

Industry at a Glance

Industry Ranking

64 / 206

Overall Ranking

160 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

OraSure Technologies Inc Highlights

StrengthsRisks

OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

Fairly Valued

The company’s latest PE is -2.88, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 65.49M shares, decreasing 13.32% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 142.96K shares of this stock.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

5.000

Target Price

+69.49%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of OraSure Technologies Inc is 6.78, ranking 111 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 27.93M, representing a year-over-year decrease of 6.70%, while its net profit experienced a year-over-year decrease of 39.51%.

Score

Industry at a Glance

Previous score

6.78

Change

0



Financials

9.83

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.82

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.32

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.80

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.13

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of OraSure Technologies Inc is 8.19, ranking 41 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.88, which is -1078.47% below the recent high of 28.17 and -858.55% above the recent low of -27.59.

Score

Industry at a Glance

Previous score

8.19

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 64/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of OraSure Technologies Inc is 7.33, ranking 137 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 4.50, with a high of 6.00 and a low of 3.00.

Score

Industry at a Glance

Previous score

7.33

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of OraSure Technologies Inc is 6.39, ranking 144 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.22 and the support level at 2.83, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.16

Change

0.23

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of OraSure Technologies Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 91.21%, representing a quarter-over-quarter increase of 0.35%. The largest institutional shareholder is James Simons, holding a total of 2.08M shares, representing 3.03% of shares outstanding, with 11.97% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Private Management Group, Inc.

5.40M

-0.39%

BlackRock Institutional Trust Company, N.A.

5.35M

-4.48%

Neuberger Berman, LLC

3.98M

-5.21%

Altai Capital Management, L.P.

3.61M

-3.39%

Dimensional Fund Advisors, L.P.

3.26M

-10.39%

Systematic Financial Management, L.P.

2.48M

-1.78%

Eglinton (Manner Carrie)

2.19M

+19.67%

Renaissance Technologies LLC

Star Investors

2.15M

-5.13%

Acadian Asset Management LLC

2.02M

-4.84%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OraSure Technologies Inc is 4.38, ranking 105 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.88. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. OraSure Technologies Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

OraSure Technologies Inc

OSUR

7.11 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment